In contrast, high AIP immunostaining was previously reported in 83% of FSH/LH-GnPT with a high Ki67 (>3%) and 21% of those with a low Ki67, further suggesting an opposite pattern as compared to somatotropinomas [19]. Here, BRD2 is linked to growth hormone-producing pituitary gland neoplasm.